Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
University of California San Diego · Western University · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
717
total citations
- FWCI
- 50.88
- Percentile
- 100%
- References
- 24
Citations per year
Authors
14Topics & keywords
Topics
Keywords
- Golimumab
- Ulcerative colitis
- Medicine
- Internal medicine
- Gastroenterology
- Colitis
- Dermatology
- Adalimumab
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.